The familial adenomatous polyposis drug pipeline analysis explores emerging therapies aimed at managing this rare inherited disorder that significantly increases the risk of colorectal cancer. With current treatments offering limited efficacy, the pipeline focuses on novel chemo-preventive agents, gene therapies, and targeted approaches to address the unmet clinical needs and reduce c... https://www.expertmarketresearch.com/clinical-trials/familial-adenomatous-polyposis-drug-pipeline-insight